<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>14496</id><no>ETCTN-10504-NCT05333458</no><status>Open</status><title>A Phase 2 Study of Atezolizumab with or Without Selinexor in Alveolar Soft Part Sarcoma (AXIOM) </title><secondary_protocol_no>10504</secondary_protocol_no><nct_id>NCT05333458</nct_id><sponsor_type>National</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>II</phase><disease_site>Other</disease_site><PI>Weinberg, Benjamin</PI><oncology_group>Sarcoma<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>Lombardi Comprehensive Cancer Center (LCCC)</management_group><item><contact_id>13105</contact_id><item_description>Christina Benedict</item_description><js_safe_str>Christina Benedict</js_safe_str><email>cnb54@georgetown.edu</email></item></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>